arrow
T

Thomas Oellerich

frankfurt cancer institute
H指数:44
被引数:5,836

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Randomized phase 3 trial of Ropeginterferon alfa-2b versus surveillance after tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia (ENDURE/CML-IX)

一项比较酪氨酸激酶抑制剂停药后罗培干扰素α-2b与观察随访治疗慢性髓性白血病(ENDURE/CML-IX)的随机Ⅲ期试验

Leukemia
IF13.4
2026-01-120
OAAI
ERBB2 signaling drives immune cell evasion and resistance against immunotherapy in small cell lung cancer

ERBB2信号驱动小细胞肺癌中的免疫细胞逃逸以及对免疫治疗的抵抗

2025-12-090
OA
Study design and rationale for the NeoTRACE trial: a multicenter phase II study of neoadjuvant sacituzumab govitecan plus zimberelimab followed by adjuvant zimberelimab with or without sacituzumab govitecan in patients with resectable non-small cell lung cancer

NeoTRACE试验的研究设计与原理:一项多中心II期研究,评估新辅助沙库巴曲舒坦联合吉米单抗,随后进行辅助吉米单抗联合或不联合沙库巴曲舒坦在可切除非小细胞肺癌患者中的应用。

2025-11-210
PRE
Clonal evolution and apoptosis resistance in myelodysplastic neoplasms and acute myeloid leukemia under treatment: insights from integrative longitudinal profiling

克隆性演化和抗凋亡性在治疗中的骨髓增生异常性肿瘤和急性髓系白血病:整合纵向分析的见解

Leukemia
IF13.4
2025-09-190
OAAI
A pooled analysis of 3 large multicenter trials confirms a survival advantage for NPM1mut AML in MRDneg remission after intensive induction

对3项大型多中心试验的合并分析证实,在强化诱导后,NPM1mut AML在MRDneg缓解期具有生存优势。

2025-08-220
OAAI
Genetic lesions in nodular lymphocyte-predominant Hodgkin lymphoma and T cell/histiocyte-rich large B-cell lymphoma identified by whole genome sequencing

通过全基因组测序确定的结节性淋巴细胞为主型霍奇金淋巴瘤和T细胞/组织细胞丰富的大B细胞淋巴瘤中的遗传病变

Leukemia
IF13.4
2025-07-160
OA
Structure-Based Design of PROTACS for the Degradation of Soluble Epoxide Hydrolase

基于结构的PROTACS设计用于可溶性环氧合酶的降解

2025-06-180
OA
CSF1R+ myeloid-monocytic cells drive CAR-T cell resistance in aggressive B cell lymphoma

CSF1R⁺髓系-单核细胞驱动侵袭性B细胞淋巴瘤中CAR-T细胞的耐药性

2025-06-120
OAAI
Epidemiology and outcomes of Candida spp. bloodstream infections in cancer patients: a comparative retrospective study from a German tertiary cancer center

念珠菌属血流感染在癌症患者中的流行病学及结局:一项来自德国三级癌症中心比较性回顾研究

2025-04-020
OA
Posttranslational Changes in Histone Modification Driven By USP48 Loss Increase Sensitivity to Hypomethylating Agents in Acute Myeloid Leukemia

USP48缺失驱动的组蛋白修饰翻译后变化增加了急性髓系白血病对低甲基化药物的敏感性

BLOOD
IF23.1
2024-11-050
PRE
AMBRA1 controls the translation of immune- specific genes in T lymphocytes

AMBRA1控制T淋巴细胞中免疫特异性基因的翻译

2024-10-220
OAAI
CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cells
2024-09-303
OAAI
RUNX1 interacts with lncRNA SMANTIS to regulate monocytic cell functions
2024-09-130
OAAI